Scholars Central

Mini reviewPublished 30 Aug 2022

Renal Osteodystrophy Treatment and Cause

Authors: Edward Martin

Journal of Interventional Nephrology

Volume 5 · Issue 4 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The term "renal osteodystrophy" is used to describe the wide variety of skeletal deformities that affect people with chronic kidney disease. The two primary disorders are adynamic bone disease, which has low bone turnover and low levels of circulating PTH, and osteoitis fibrosa, which is characterised by fast bone turnover, enhanced osteoclastic and osteoblastic activity, and high levels of circulating parathyroid hormone (PTH). Renal osteodystrophy is primarily caused by the retention of phosphorus, decreased blood levels of calcitriol, lower levels of serum ionised calcium, decreased numbers of vitamin D receptors and calcium sensors in the parathyroid gland, and skeletal resistance to PTH's calcemic activity. The current strategy for treating renal osteodystrophy will be discussed in this review [1].

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Interventional Nephrology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Interventional Nephrology
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Edward Martin”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels